Total Payments
$5,963
2024 Payments
$4,865
Companies
14
Transactions
53
Medicare Patients
2,766
Medicare Billing
$377,492

Payment Breakdown by Category

Education$4,000 (67.1%)
Food & Beverage$1,344 (22.5%)
Travel$619.07 (10.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $4,000 2 67.1%
Food and Beverage $1,344 47 22.5%
Travel and Lodging $619.07 4 10.4%

Top Paying Companies

Company Total Records Latest Year
INTUITIVE SURGICAL, INC. $4,668 7 $0 (2024)
GlaxoSmithKline, LLC. $868.93 25 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $155.66 3 $0 (2023)
Grifols USA, LLC $65.30 4 $0 (2019)
AstraZeneca Pharmaceuticals LP $56.86 4 $0 (2022)
Respiratory Technologies, Inc. $28.94 2 $0 (2017)
Philips North America LLC $18.47 1 $0 (2024)
Genentech USA, Inc. $18.07 1 $0 (2018)
PORTOLA PHARMACEUTICALS, INC. $17.80 1 $0 (2018)
Philips Electronics North America Corporation $16.25 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,865 17 INTUITIVE SURGICAL, INC. ($4,668)
2023 $428.16 11 GlaxoSmithKline, LLC. ($405.32)
2022 $137.57 2 GlaxoSmithKline, LLC. ($124.54)
2019 $157.49 5 GlaxoSmithKline, LLC. ($130.51)
2018 $136.50 9 AstraZeneca Pharmaceuticals LP ($29.36)
2017 $238.60 9 Boehringer Ingelheim Pharmaceuticals, Inc. ($114.25)

All Payment Transactions

53 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/14/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $7.66 General
Category: IMMUNOLOGY
08/20/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $6.71 General
Category: IMMUNOLOGY
07/09/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $48.69 General
Category: SURGERY
06/25/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $6.32 General
Category: RESPIRATORY
06/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $4.82 General
Category: RESPIRATORY
06/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $1.64 General
Category: RESPIRATORY
06/11/2024 Ambu Inc. Food and Beverage Cash or cash equivalent $13.94 General
05/22/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $121.17 General
Category: IMMUNOLOGY
05/01/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $11.88 General
Category: RESPIRATORY
04/23/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $4.77 General
Category: RESPIRATORY
04/16/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education In-kind items and services $1,500.00 General
Category: SURGERY
03/31/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $85.00 General
Category: SURGERY
03/28/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $254.11 General
Category: SURGERY
03/27/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education In-kind items and services $2,500.00 General
Category: SURGERY
02/29/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $254.96 General
Category: SURGERY
02/29/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $25.00 General
Category: SURGERY
01/12/2024 Philips North America LLC (8874) inCourage (Device) Food and Beverage Cash or cash equivalent $18.47 General
Category: Medical Device
11/13/2023 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $5.55 General
Category: RESPIRATORY
10/31/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.84 General
Category: DIABETES
10/23/2023 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX Food and Beverage In-kind items and services $12.48 General
Category: RESPIRATORY
10/04/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $5.72 General
Category: IMMUNOLOGY
09/27/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $20.89 General
Category: IMMUNOLOGY
09/14/2023 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $120.86 General
Category: RESPIRATORY
08/29/2023 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $5.05 General
Category: RESPIRATORY
07/26/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $3.60 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 686 1,027 $269,926 $88,913
2022 14 633 917 $249,570 $85,273
2021 15 648 1,022 $265,971 $95,417
2020 14 799 1,193 $302,518 $107,889
Total Patients
2,766
Total Services
4,159
Medicare Billing
$377,492
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 64 165 $100,627 $26,573 26.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 83 155 $34,874 $14,646 42.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 128 190 $28,880 $12,733 44.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 90 186 $28,841 $11,395 39.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 74 80 $33,580 $10,890 32.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 50 51 $14,535 $5,176 35.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 50 50 $11,150 $3,606 32.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 20 $4,460 $1,921 43.1%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 13 13 $8,366 $820.45 9.8%
94726 Test to determine lung volumes using sensors Facility 2023 35 35 $1,155 $320.28 27.7%
94618 Test for exercise-induced lung stress Office 2023 12 13 $1,313 $319.92 24.4%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 35 35 $1,295 $274.72 21.2%
94729 Test to examine how well the lungs exchange gases Facility 2023 34 34 $850.00 $238.00 28.0%
99291 Critical care, first 30-74 minutes Facility 2022 64 130 $78,682 $22,230 28.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 94 100 $41,960 $15,636 37.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 130 193 $29,018 $13,076 45.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 78 154 $34,620 $12,563 36.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 88 154 $23,870 $8,721 36.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 33 37 $8,215 $3,531 43.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 37 37 $8,170 $3,271 40.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 28 28 $7,980 $2,872 36.0%
99292 Critical care, each additional 30 minutes Facility 2022 20 22 $6,514 $1,921 29.5%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2022 12 13 $7,960 $883.17 11.1%
94618 Test for exercise-induced lung stress Office 2022 15 15 $1,515 $350.09 23.1%
94726 Test to determine lung volumes using sensors Facility 2022 12 12 $390.00 $86.72 22.2%

About Dr. Vikram Oke, M.D

Dr. Vikram Oke, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1285905158.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Oke, M.D has received a total of $5,963 in payments from pharmaceutical and medical device companies, with $4,865 received in 2024. These payments were reported across 53 transactions from 14 companies. The most common payment nature is "Education" ($4,000).

As a Medicare-enrolled provider, Oke has provided services to 2,766 Medicare beneficiaries, totaling 4,159 services with total Medicare billing of $377,492. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

Products in Payments

  • Da Vinci Surgical System (Device) $4,668
  • NUCALA (Biological) $298.39
  • AREXVY (Drug) $150.26
  • TRELEGY ELLIPTA (Drug) $147.65
  • ANORO (Drug) $131.45
  • Prolastin-C (Biological) $38.32
  • Prolastin-C Liquid (Biological) $26.98
  • JARDIANCE (Drug) $22.84
  • STIOLTO RESPIMAT (Drug) $18.57
  • (8874) inCourage (Device) $18.47
  • Xolair (Biological) $18.07
  • BEVYXXA (Drug) $17.80
  • Wellcentive Undiv (Device) $16.25
  • SYMBICORT (Drug) $14.89
  • FASENRA (Drug) $14.47
  • BREZTRI (Drug) $13.03
  • XOLAIR (Biological) $12.72
  • ACTHAR (Biological) $12.36
  • TUDORZA PRESSAIR (Drug) $10.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Pikeville